oxophenylarsine has been researched along with Leukemia, Mast-Cell in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Leukemia, Mast-Cell: A form of systemic mastocytosis (MASTOCYTOSIS, SYSTEMIC) characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumada, T | 1 |
| Nakashima, S | 1 |
| Nakamura, Y | 1 |
| Miyata, H | 1 |
| Nozawa, Y | 1 |
1 other study available for oxophenylarsine and Leukemia, Mast-Cell
| Article | Year |
|---|---|
Phenylarsine oxide (PAO)-mediated activation of phospholipase D in rat basophilic leukemia (RBL-2H3) cells: possible involvement of calcium and protein kinase C.
Topics: Animals; Antigens; Arsenicals; Calcium; Dimercaprol; Dithiothreitol; Enzyme Activation; Leukemia, Ma | 1996 |